勝又 康弘 かつまた やすひろ 先生

来歴等

略歴

1997年 筑波大学医学専門学群 卒業
1997年 東京女子医科大学 初期研修医
1999年 東京女子医科大学 練生
2005年 東京女子医科大学附属膠原病リウマチ痛風センター 助手
2008年 東京女子医科大学附属膠原病リウマチ痛風センター 助教
2012年 東京女子医科大学附属膠原病リウマチ痛風センター 講師
2018年 東京女子医科大学医学部膠原病リウマチ内科学分野 講師

論文

• 1. Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan; Members of the Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan: In addition to the authors, the following investigators and institutions participated in this study:.Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort. Immunol Med. 2025;48(1):47-57.

  Katsumata Y, Sada KE, Kameda T, Dobashi H, Kaname S, Tsuboi N, Matsumoto Y, Amano K, Tamura N, Harigai M.

• 2. Asia-Pacific Lupus Collaboration. Risk of Flare and Damage Accrual after Tapering Glucocorticoids in Modified Serologically Active Clinically Quiescent Patients with Systemic Lupus Erythematosus: A Multinational Observational Cohort Study. Ann Rheum Dis. 2024 Jul 15;83(8):998-1005.

  Katsumata Y, Inoue E, Harigai M, Cho J, Louthrenoo W, Hoi A, Golder V, Lau CS, Lateef A, Chen YH, Luo SF, Wu YJ, Hamijoyo L, Li Z, Sockalingam S, Navarra S, Zamora L, Hao Y, Zhang Z, Chan M, Oon S, Ng K, Kikuchi J, Takeuchi T, Goldblatt F, O'Neill S, Tugnet N, Law AHN, Bae SC, Tanaka Y, Ohkubo N, Kumar S, Kandane-Rathnayake R, Nikpour M, Morand EF.

• 3. Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods. Immunol Med. 2020;43(1):47-56.

  Katsumata Y, Okamoto Y, Moriyama T, Moriyama R, Kawamoto M, Hanaoka M, Uchida K, Nitta K, Harigai M.

• 4. Serum antibodies against the 70k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus: a retrospective study. Mod Rheumatol. 2013;23:71-80.

  Katsumata Y, Kawaguchi Y, Baba S, Hattori S, Tahara K, Ito K, Iwasaki T, Yamaguchi N, Hattori H, Nagata K, Okamoto Y, Yamanaka H, Hara M.

• 5. Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases. Mod Rheumatol. 2012;22:676-84.

  Katsumata Y, Kawachi I, Kawaguchi Y, Gono T, Ichida H, Hara M, Yamanaka H.

• 6. Anti–C1q Antibodies are Associated with Systemic Lupus Erythematosus Global Activity, but not Specifically with Nephritis: A Controlled Study of 126 Consecutive Patients. Arthritis Rheum. 2011;63:2436-44.

  Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.

• 7. Identification of Three New Autoantibodies Associated with Systemic Lupus Erythematosus Using a Refined Proteomic Approach. Mol Cell Proteomics. 2011;10:M110.005330.

  Katsumata Y, Kawaguchi Y, Baba S, Hattori S, Tahara K, Ito K, Iwasaki T, Yamaguchi N, Oyama M, Kozuka–Hata H, Hattori H, Nagata N, Yamanaka H, Hara M.

• 8. Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study. BMC Musculoskelet Disord. 2010;11:13.

  Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Kanno T, Nishimura K, Yamada T, Yamanaka H, Hara M.

• 9. Diagnostic Reliability of Cerebral Spinal Fluid Tests for Acute Confusional State (Delirium) in Patients with Systemic Lupus Erythematosus: Interleukin 6 (IL-6), IL-8, Interferon-alpha, IgG Index, and Q-Albumin. J Rheumatol. 2007;34:2010-7.

  Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanaka M, Ichida H, Tochimoto A, Kanno T, Nishimura K, Kamatani N, Hara M.

• 10. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J Autoimmun. 2007;29:174-86.

  Katsumata Y, Ridgway WM, Oriss T, Gu X, Chin D, Wu Y, Fertig N, Oury T, Vandersteen D, Clemens P, Camacho CJ, Weinberg A, Ascherman DP.

• 11. Attenuation of Experimental Autoimmune Myositis by Blocking ICOS-ICOS Ligand Interaction. J Immunol. 2007;179:3772-3779.

  Katsumata Y, Harigai M, Sugiura T, Kawamoto M, Kawaguchi Y, Matsumoto Y, Kohyama K, Soejima M, Kamatani N, Hara M.

• 12. Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis. Arthritis Rheum. 2003;48:1647-51.

  Katsumata Y, Suzuki T, Kuwana M, Hattori Y, Akizuki S, Sugiura H, Matsuoka Y.

受賞

• 2011年 日本リウマチ学会 奨励賞